A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa,India

被引:0
|
作者
Babu BV [1 ]
机构
[1] Division of Epidemiology,Regional Medical Research Centre,Indian Council of Medical Research,Bhubaneswar-751 023,India & Indian Council of Medical Research,New Delhi 110 029,India
关键词
Lymphatic filariasis; Mass drug administration; Adverse reactions; Qualitative study; Orissa; India;
D O I
暂无
中图分类号
R532.15 [丝虫病(象皮病)];
学科分类号
1002 ; 100201 ;
摘要
Objective:To describe the perceptions of community members and programme partners regarding severity,management and impact of adverse reactions on mass drug administration (MDA) compliance.Methods:Based on various qualitative data collected from five districts of Orissa,India,where MDA had been implemented during 2002 and 2004.The qualitative surveys included focus group discussions with community members and health workers,and semi-structured interviews with key informants in the community,medical officers at primary health centres,district level health officers and private practitioners.Results:It showed that many people suffered from adverse reactions,though the reactions were not serious.The paper reported different ways of management of adverse reactions at the community level.The impact of adverse reactions on MDA compliance was serious,as many people did not consume the drug due to fear of adverse reactions.The rumours of adverse reactions and news in media deterred people from consuming the tablets.Conclusion:All categories of respondents indicates the need of more information to address the problem of adverse reactions during MDA.The present paper warrants incorporating the messages on adverse reactions during health communication and social mobilization campaigns of MDA.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 50 条
  • [31] Impact of Community-Based Lymphedema Management on Perceived Disability among Patients with Lymphatic Filariasis in Orissa State, India
    Budge, Philip J.
    Little, Kristen M.
    Mues, Katherine E.
    Kennedy, Erin D.
    Prakash, Aiysha
    Rout, Jonathan
    Fox, LeAnne M.
    PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (03):
  • [32] Data reporting constraints for the lymphatic filariasis mass drug administration activities in two districts in Ghana: A qualitative study
    Vroom, Frances Baaba da-Costa
    Aryeetey, Richmond
    Boateng, Richard
    Anto, Francis
    Aikins, Moses
    Gyapong, Margaret
    Gyapong, John
    SAGE OPEN MEDICINE, 2015, 3
  • [33] ENDING MASS TREATMENT FOR LYMPHATIC FILARIASIS IN 87 HEALTH DISTRICTS IN CAMEROON
    Benjamin, Biholong
    Clarisse, Ebene
    Akame, Julie
    Mbia, Patrick
    Fokam, Carine
    Hendji, Michel
    Zhang, Yaobi
    Reid, Steven
    Nko'Ayissi, Georges
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 166 - 166
  • [34] Mass drug administration to eliminate lymphatic filariasis: A population-based coverage and compliance study in Eastern India
    Mohanty, Shubhashisha
    Behera, Birasen
    Sinha, Abhinav
    Bal, Madhusmita
    Pati, Sanghamitra
    Sahoo, Prakash Kumar
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 30
  • [35] Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
    Banerjee, Sitikantha
    Bandyopadhyay, Kajari
    Khan, Mubashshera F.
    Akkilagunta, Sujiv
    Selvaraj, Kalaiselvi
    Tripathy, Jaya P.
    Solanki, Ranjan
    Kushwaha, Arvind S.
    Deshmukh, Pradeep
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (09) : 3009 - 3014
  • [36] Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India
    Nujum, Zinia T.
    INTERNATIONAL HEALTH, 2011, 3 (01): : 22 - 26
  • [37] Assessment of mass drug administration program to eliminate lymphatic filariasis in an urban endemic area of filariasis in North Kerala, India
    Karunakaran, U.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E163 - E163
  • [38] Facilitators and barriers in implementation of mass drug administration for lymphatic filariasis elimination in India: A protocol for systematic review and qualitative meta-synthesis
    Sinha, Abhinav
    Mohapatra, Sumegha
    Pati, Sanghamitra
    Sahoo, Prakash Kumar
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (07) : 3844 - 3850
  • [39] PERCEPTIONS AND REPORTED SEVERITY OF ADVERSE EVENTS FOLLOWING TREATMENT FOR LYMPHATIC FILARIASIS: RESULTS OF A MULTICENTER COMMUNITY BASED STUDY
    Krentel, Alison
    Mallya, Shruti
    Goss, Charles W.
    Thickstun, Charles
    Dilliott, Daniel
    Basker, Nandha
    Jambulingam, Purushothaman
    De Rochars, Valery Madsen Beau
    Direny, Abdel N.
    Lemoine, Jean Frantz
    Ga, Adriani Lomi
    Supali, Taniawati
    Bogus, Joshua
    Howard, Cade
    Kerry, Zebedee
    Robinson, Leanne J.
    Hardy, Myra
    Steer, Andrew C.
    Samuela, Josaia
    Schechtman, Ken B.
    Fischer, Peter U.
    King, Christopher L.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 199 - 200
  • [40] LYMPHATIC FILARIASIS: HOST AND PARASITE FACTORS AND THE PATHOGENESIS OF SYSTEMIC ADVERSE EVENTS FOLLOWING TREATMENT
    Andersen, Britt
    Kumar, Jessica
    King, Christopher L.
    Fischer, Peter Uwe
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 587 - 587